Media Summary: "You can't just sit back and be a spectator. You have to get into the fight and be a participant in this journey that we're all on. Dr. Victor Sandor talks about the latest developments at

Meet Gary Array Biopharma - Detailed Analysis & Overview

"You can't just sit back and be a spectator. You have to get into the fight and be a participant in this journey that we're all on. Dr. Victor Sandor talks about the latest developments at

Photo Gallery

Meet Gary - Array BioPharma
Meet Anne - Array BioPharma
Meet the Scientist - Array BioPharma
Gary Hingorani of Array Biopharma and developing a cure for Purple Sneezitis
Science Meets Gratitude - Array BioPharma
Pfizer buys Array Biopharma for $48/share in cash
PropThink Interviews: Array BioPharma
Array Biopharma waiting on approval for skin cancer drugs
Dr. Gary Mangiofico  | The Long Grey Line Project
Why Pfizer Is Buying Array BioPharma for $10.6 Billion
Pfizer acquires array biopharma in $10.64B deal
Overview of the NEMO Trial, Encorafenib for CRC
View Detailed Profile
Meet Gary - Array BioPharma

Meet Gary - Array BioPharma

When

Meet Anne - Array BioPharma

Meet Anne - Array BioPharma

"You can't just sit back and be a spectator. You have to get into the fight and be a participant in this journey that we're all on.

Meet the Scientist - Array BioPharma

Meet the Scientist - Array BioPharma

Go behind the scenes and "

Gary Hingorani of Array Biopharma and developing a cure for Purple Sneezitis

Gary Hingorani of Array Biopharma and developing a cure for Purple Sneezitis

Explore how medicine gets made.

Science Meets Gratitude - Array BioPharma

Science Meets Gratitude - Array BioPharma

Clinical trial participant

Pfizer buys Array Biopharma for $48/share in cash

Pfizer buys Array Biopharma for $48/share in cash

Dow component Pfizer is buying

PropThink Interviews: Array BioPharma

PropThink Interviews: Array BioPharma

Ron Squarer, Chief Executive of

Array Biopharma waiting on approval for skin cancer drugs

Array Biopharma waiting on approval for skin cancer drugs

Array Biopharma

Dr. Gary Mangiofico  | The Long Grey Line Project

Dr. Gary Mangiofico | The Long Grey Line Project

Learn how Dr.

Why Pfizer Is Buying Array BioPharma for $10.6 Billion

Why Pfizer Is Buying Array BioPharma for $10.6 Billion

Jun.17 -- Pfizer Inc. will buy

Pfizer acquires array biopharma in $10.64B deal

Pfizer acquires array biopharma in $10.64B deal

Pfizer is buying

Overview of the NEMO Trial, Encorafenib for CRC

Overview of the NEMO Trial, Encorafenib for CRC

Dr. Victor Sandor talks about the latest developments at

IBM Vice Chairman Gary Cohn on whether the U.S. is overbuilding data centers

IBM Vice Chairman Gary Cohn on whether the U.S. is overbuilding data centers

IBM Vice Chairman